Although many antidepressant (AD) drugs of different classes are available, two major problems remain unsolved. The first is that there is almost always a lag period before they are effective, and the second that 20-30 percent of depressed patients do not respond adequately to AD medication. Several agents including the thyroid hormones triiodothyronine (T3) and thyroxine (T4) have been used to reduce the lag period of ADs and augment their effects in refractory patients. Work in our laboratory has focussed on basic mechanisms of such augmenting agents, which are only minimally understood, in order to strengthen the scientific basis for their clinical application. The focus of this proposal is on T3 and on the hypothesis that increased synaptic availability of serotonin (5-HT) and effects on 5-HT receptors of the 5-HT-1A and 5-HT-1B subtypes are pivotal to the augmentation of ADs by thyroid hormones. Our preliminary experiments have shown that 7-day administration of T3 to rats increases basal levels of 5-HT, as determined by in vivo microdialysis, in frontal cortex, and also potentiates the increase in 5-HT levels induced by chronic administration of clomipramine. In the present project we seek to establish the relationship between T3 and 5-HT levels by performing dose-dependence and time course studies, in the latter case both with T3 alone and with T3 given in conjunction with an AD. As well as measuring basal 5-HT levels, presynaptic 5-HT-1A receptor functioning will be determined by the effect of the 5-HT-1A receptor agonist 8-OH-DPAT to reduce 5-HT release as a result of somatodendritic autoreceptor activation. Terminal 5-HT-1B autoreceptor function will be assessed using the 5-HT-1B/1D receptor antagonist GR 127935. These measurements of presynaptic function will be performed in frontal cortex, hippocampus and hypothalamus since all these areas have been implicated in the pathology of depression. Post-synaptic 5-HT-1A receptor functioning in the hippocampus will be determined by the effect of 8-OH-DPAT on cyclic AMP levels. Post-synaptic 5-HT-1A receptor functioning in the hypothalamus will be measured by means of neuroendocrine challenge tests in which 8-OH-DPAT -induced release of plasma corticosterone, ACTH and oxytocin is measured. In addition, mRNA levels for the 5-HT-1A and 5-HT-1B receptors, and protein levels, will be determined in a variety of brain areas including pre- and post-synaptic sites. These experiments will permit a comprehensive assessment of the role of serotonergic mechanisms in AD augmentation by T3 and an empirical basis for its use in the treatment of depression.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH060580-03
Application #
6660786
Study Section
Special Emphasis Panel (ZRG1-BDCN-6 (01))
Program Officer
Brady, Linda S
Project Start
2001-08-05
Project End
2004-07-31
Budget Start
2003-08-01
Budget End
2004-07-31
Support Year
3
Fiscal Year
2003
Total Cost
$77,999
Indirect Cost
Name
Hadassah-Hebrew University Medical Center
Department
Type
DUNS #
600063937
City
Jerusalem
State
Country
Israel
Zip Code
91120
Lifschytz, Tsuri; Segman, Ronen; Shalom, Galit et al. (2006) Basic mechanisms of augmentation of antidepressant effects with thyroid hormone. Curr Drug Targets 7:203-10
Lifschytz, Tzuri; Shalom, Galit; Lerer, Bernard et al. (2006) Sex-dependent effects of fluoxetine and triiodothyronine in the forced swim test in rats. Eur Neuropsychopharmacol 16:115-21
Lifschytz, Tzuri; Gur, Eitan; Lerer, Bernard et al. (2004) Effects of triiodothyronine and fluoxetine on 5-HT1A and 5-HT1B autoreceptor activity in rat brain: regional differences. J Neurosci Methods 140:133-9
Gur, Eitan; Lifschytz, Tsuri; Van De Kar, Louis D et al. (2004) Effects of triiodothyronine on 5-HT(1A) and 5-HT(1B) autoreceptor activity, and postsynaptic 5-HT(1A) receptor activity, in rat hypothalamus: lack of interaction with imipramine. Psychoneuroendocrinology 29:1172-83
Newman, Michael E; Shalom, Galit; Ran, Avigail et al. (2004) Chronic fluoxetine-induced desensitization of 5-HT1A and 5-HT1B autoreceptors: regional differences and effects of WAY-100635. Eur J Pharmacol 486:25-30
Shalom, Galit; Gur, Eitan; Van de Kar, Louis D et al. (2004) Repeated administration of the 5-HT(1B) receptor antagonist SB-224289 blocks the desensitisation of 5-HT(1B) autoreceptors induced by fluoxetine in rat frontal cortex. Naunyn Schmiedebergs Arch Pharmacol 370:84-90
Dremencov, Eliyahu; Gur, Eitan; Lerer, Bernard et al. (2003) Effects of chronic antidepressants and electroconvulsive shock on serotonergic neurotransmission in the rat hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 27:729-39
Gur, Eitan; Lifschytz, Tsuri; Lerer, Bernard et al. (2002) Effects of triiodothyronine and imipramine on basal 5-HT levels and 5-HT(1) autoreceptor activity in rat cortex. Eur J Pharmacol 457:37-43